Kyle Serikawa works as a Project Manager in Type 1 Diabetes at the Benaroya Research Institute and also has a private consulting practice in genomics and enabling technologies. He is a recent graduate and current board member for Leadership Tomorrow in Seattle. After getting his undergraduate degree at Carleton College in Minnesota, Kyle realized he only likes snow in short, controlled bursts and moved to Berkeley for his PhD in Genetics and then to the University of Washington for his postdoctoral work, where he studied algal morphology of all things. In addition to his academic work, he has had the opportunity to work for Merck and Novo Nordisk. He has a strong interest in finding new and innovative ways to increase patient health.
Let me make a modest proposal: Seattle should commit to sequencing and interpreting the genomes of every willing member of its population and should do it within the next five years. ... Read more »
My 9-year-old son is addicted to “Let’s Play” videos on YouTube. You watch videos that take you through level after level of a video game, giving you a preview of what’s... Read more »
Consider a candidate. Selecting that candidate takes thousands of hours of time and research–checking background, verifying data, assessing probabilities, projecting futures. Once selected, more years of development follow, during which time... Read more »
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.